Myra Mahon Patient Resource Center

The Asian Smokers' Quitline is a free nationwide Asian-language quit smoking service operated by the Moores Cancer Center at the University of California, San Diego. The Quitline offers self-help materials, one-on-one telephone counseling to quit smoking, and a free two-week starter kit of nicotine patches. Quitline services have been proven in clinical trials to double a smoker's chances of successfully quitting.

Funded by the Centers for Disease Control and Prevention (CDC), the Asian Smokers Quitline is a phone-based, free service for those desiring to quite smoking. Services are available in five languages (English, Cantonese, Mandarin, Korean, and Vietnamese). - Chinese (Cantonese and Mandarin): 1-800-838-8917 - Korean: 1-800-556-5564 - Vietnamese: 1-800-778-8440

The Quitline also provides information to friends and family members of tobacco users. Resources for states to promote the service in their communities are included.

Translations of The Health Care Law and You, developed by the U.S. Department of Health and Human Services to educate community members about the benefits of the Affordable Care Act, are now available in 10 Asian and Asian Pacific languages.

This resource has been translated by the Office of Public Engagement at the Centers for Medicare & Medicaid Services into the following languages: Chinese, Korean, Vietnamese, Tagalog, Hindi, Bengali, Hmong, Khmer, Laotian, Samoan and Tongan.

Webinars that delve deeper into these materials will take place in late May. New in-language materials and resources about the health reform law will continue to be added to the site throughout the coming months.

For more information, visit APIAHF (Asian & Pacific Islander American Health Forum)

Research by the National Alliance for Hispanic Health (NAHH) found that more than half of Hispanic consumers are not aware of the health risks associated with taking too much acetaminophen, and do not check medicine labels to see if their medicine contains acetaminophen.

NAHH and the Acetaminophen Awareness Coalition's Know Your Dose Campaign have joined together to launch new web-based resources and educational materials in Spanish about safe acetaminophen use.

Visit Know Your Dose to order free, patient educational materials in English and Spanish. The site includes a Spanish-language section with a medicine-label reader guide, answers to frequently asked questions and an animated video on safe use of medicines containing acetaminophen, produced by the NAHH.

Patients can call the toll-free Su Familia Helpline at 1-866-783-2645 for answers to questions about safe acetaminophen use and referrals to health resources in their communities.

To learn more, visit KnowYourDose.org (Acetaminophen Awareness Coalition)

In observance of Food Allergy Awareness Week 2013, NIAID encourages the public to learn more about and share valuable information about food allergy. Following are online resources about food allergy:

• The NIAID website explains food allergy, NIAID's role in food allergy research, and provides a summary of the Guidelines for the Diagnosis and Management of Food Allergy in the United States (PDF).

• ClinicalTrials.gov lists NIAID-sponsored food allergy studies that are currently enrolling volunteers.

• The U.S. Centers for Disease Control and Prevention website addresses efforts to protect children with food allergies in the school environment.

• The U.S. Department of Agriculture website describes the federal laws requiring that all food ingredients be listed on the food label.

Medicare, the Federal health insurance program for adults 65+ and others who qualify, helps pay for inpatient care at hospitals under Medicare Part A. Find out what types of hospital care are covered by Medicare Part A.

To learn more, take this short quiz on basic information about Medicare.

The information on Medicare Basics was provided by NIHSeniorHealth and developed by the Centers for Medicaid and Medicare (CMS).

If you, or someone you know, has had a heart attack, a diagnosis of cerebrovascular atherosclerotic disease, peripheral arterial disease or diabetes mellitus with documented coronary artery disease, you may be eligible to participate in a clinical research trial.

The Cardiac Prevention Center at Weill Cornell Medical College is conducting a research trial for people with above medical history. This study is evaluating the effect of treatment with a cholesterol-lowering investigational drug compared with placebo.

We are seeking men and women, 18 years of age or older, with the above conditions to participate in a research trial which may last up to 4 years. Participation will also depend on other requirements. Health insurance is not necessary to participate.

If you are eligible to participate in this research study you will receive the following at no cost:
- Physical Exams
- Laboratory Testing
- Research Related Care
- May be reimbursed per visit for travel expenses

For more information, please contact:
Bassem Masri, M.D.
(646) 962-6035
mco2002@med.cornell.edu

IRB Protocol #1209012992